Live feed09:00:00·1092dPRReleasevia QuantisnowAlnylam Announces Date of Planned FDA Advisory Committee Meeting for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR AmyloidosisByQuantisnow·Wall Street's wire, on your screen.ALNY· Alnylam Pharmaceuticals Inc.Health Care
